Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cancer immunotherapy.
Baxevanis CN, Perez SA, Papamichail M. Baxevanis CN, et al. Crit Rev Clin Lab Sci. 2009;46(4):167-89. doi: 10.1080/10408360902937809. Crit Rev Clin Lab Sci. 2009. PMID: 19650714 Free article. Review.
Peripheral T cell responses to tumour antigens are associated with molecular, immunogenetic and cellular features of breast cancer patients.
Janssen N, Fortis SP, Speigl L, Haritos C, Sotiriadou NN, Sofopoulos M, Arnogiannaki N, Stavropoulos-Giokas C, Dinou A, Perez S, Pawelec G, Baxevanis CN, Shipp C. Janssen N, et al. Among authors: baxevanis cn. Breast Cancer Res Treat. 2017 Jan;161(1):51-62. doi: 10.1007/s10549-016-4037-z. Epub 2016 Oct 27. Breast Cancer Res Treat. 2017. PMID: 27787640
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer.
Fortis SP, Sofopoulos M, Sotiriadou NN, Haritos C, Vaxevanis CK, Anastasopoulou EA, Janssen N, Arnogiannaki N, Ardavanis A, Pawelec G, Perez SA, Baxevanis CN. Fortis SP, et al. Among authors: baxevanis cn. J Immunother Cancer. 2017 Apr 18;5:39. doi: 10.1186/s40425-017-0240-7. eCollection 2017. J Immunother Cancer. 2017. PMID: 28428887 Free PMC article.
Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer.
Fortis SP, Sofopoulos M, Sotiriadou NN, Haritos C, Vaxevanis CK, Anastasopoulou EA, Janssen N, Arnogiannaki N, Ardavanis A, Pawelec G, Perez SA, Baxevanis CN. Fortis SP, et al. Among authors: baxevanis cn. J Immunother Cancer. 2017 May 30;5:48. doi: 10.1186/s40425-017-0248-z. eCollection 2017. J Immunother Cancer. 2017. PMID: 28572978 Free PMC article.
Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics.
Fortis SP, Vaxevanis CK, Mahaira LG, Sofopoulos M, Sotiriadou NN, Dinou A, Arnogiannaki N, Stavropoulos-Giokas C, Thanos D, Baxevanis CN, Perez SA. Fortis SP, et al. Among authors: baxevanis cn. Cancer Immunol Immunother. 2019 Jan;68(1):57-70. doi: 10.1007/s00262-018-2252-7. Epub 2018 Oct 1. Cancer Immunol Immunother. 2019. PMID: 30276443 Free PMC article.
Prostate cancer: any room left for immunotherapies?
Baxevanis CN, Fortis SP, Perez SA. Baxevanis CN, et al. Immunotherapy. 2019 Feb;11(2):69-74. doi: 10.2217/imt-2018-0159. Immunotherapy. 2019. PMID: 30727800 No abstract available.
181 results